{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T11:08:13Z","timestamp":1775646493888,"version":"3.50.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3,5]]},"DOI":"10.4103\/0366-6999.176987","type":"journal-article","created":{"date-parts":[[2016,2,19]],"date-time":"2016-02-19T07:31:08Z","timestamp":1455867068000},"page":"562-569","source":"Crossref","is-referenced-by-count":16,"title":["Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease"],"prefix":"10.1097","volume":"129","author":[{"given":"Rong-Shuang","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ming","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Xi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sehee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20210129","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/oxfordjournals.ndt.a027312","article-title":"Proteinuria and blood pressure as causal components of progression to end-stage renal failure. Northern Italian Cooperative Study Group","volume":"11","author":"Locatelli","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"R2-10-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9343(00)00444-7","article-title":"Proteinuria as a risk factor for cardiovascular disease and mortality in older people:A prospective study","volume":"109","author":"Culleton","year":"2000","journal-title":"Am J Med"},{"key":"R3-10-20210129","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2165\/00003495-200565002-00005","article-title":"Renal protection in hypertensive patients: Selection of antihypertensive therapy","volume":"65","author":"Wenzel","year":"2005","journal-title":"Drugs"},{"key":"R4-10-20210129","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2515\/therapie\/2009047","article-title":"Angiotensin converting enzyme inhibitors and calcium antagonists: A synergistic action for a better prevention of cardiovascular events","volume":"64","author":"Boutouyrie","year":"2009","journal-title":"Therapie"},{"key":"R5-10-20210129","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.2147\/VHRM.S4073","article-title":"The evolution of systolic blood pressure as a strong predictor of cardiovascular risk and the effectiveness of fixed-dose ARB\/CCB combinations in lowering levels of this preferential target","volume":"4","author":"Mourad","year":"2008","journal-title":"Vasc Health Risk Manag"},{"key":"R6-10-20210129","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"R8-10-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: Is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"R10-10-20210129","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"R12-10-20210129","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1046\/j.1523-1755.1998.00083.x","article-title":"Effects of an ACE inhibitor\/calcium antagonist combination on proteinuria in diabetic nephropathy","volume":"54","author":"Bakris","year":"1998","journal-title":"Kidney Int"},{"key":"R13-10-20210129","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/hr.2011.101","article-title":"Angiotensin II receptor blocker and long-acting calcium channel blocker combination therapy decreases urinary albumin excretion while maintaining glomerular filtration rate","volume":"34","author":"Nakagawa","year":"2011","journal-title":"Hypertens Res"},{"key":"R14-10-20210129","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.2215\/CJN.01110210","article-title":"Combined therapy with renin-angiotensin system and calcium channel blockers in type 2 diabetic hypertensive patients with proteinuria: Effects on soluble TWEAK, PTX3, and flow-mediated dilation","volume":"5","author":"Yilmaz","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R15-10-20210129","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1093\/ndt\/16.11.2158","article-title":"The effects of an ACE inhibitor and a calcium antagonist on the progression of renal disease: The nephros study","volume":"16","author":"Herlitz","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"R16-10-20210129","first-page":"375","article-title":"A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension","volume":"55","author":"Petersen","year":"2001","journal-title":"Clin Nephrol"},{"key":"R17-10-20210129","doi-asserted-by":"crossref","first-page":"c139","DOI":"10.1159\/000086714","article-title":"A prospective open-label randomised trial of quinapril and\/or amlodipine in progressive non-diabetic renal failure","volume":"101","author":"MacGregor","year":"2005","journal-title":"Nephron Clin Pract"},{"key":"R18-10-20210129","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/HYPERTENSIONAHA.111.174474","article-title":"Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: The delapril and manidipine for nephroprotection in diabetes (DEMAND) randomized clinical trial","volume":"58","author":"Ruggenenti","year":"2011","journal-title":"Hypertension"},{"key":"R19-10-20210129","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(05)71082-5","article-title":"Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2):Multicentre, randomised controlled trial","volume":"365","author":"Ruggenenti","year":"2005","journal-title":"Lancet"},{"key":"R20-10-20210129","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1046\/j.1523-1755.1999.00434.x","article-title":"Class differences in the effects of calcium channel blockers in the rat remnant kidney model","volume":"55","author":"Griffin","year":"1999","journal-title":"Kidney Int"},{"key":"R21-10-20210129","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11886-008-0071-8","article-title":"Potential risks of calcium channel blockers in chronic kidney disease","volume":"10","author":"Griffin","year":"2008","journal-title":"Curr Cardiol Rep"},{"key":"R22-10-20210129","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0140-6736(01)06411-X","article-title":"Cardiovascular protection and blood pressure reduction: A meta-analysis","volume":"358","author":"Staessen","year":"2001","journal-title":"Lancet"},{"key":"R23-10-20210129","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/0366-6999.176987","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T19:38:15Z","timestamp":1623958695000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00029330-201603050-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.4103\/0366-6999.176987","relation":{},"ISSN":["0366-6999"],"issn-type":[{"value":"0366-6999","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3,5]]}}}